Views

CrossRef citations to date

Altmetric

Original Article

A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease

Yasufumi MasakiDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan, Correspondence[email protected]

Shoko MatsuiFirst Department of Internal Medicine, University of Toyama, Toyama, Japan,

Takako SaekiDepartment of Internal Medicine, Nagaoka Red Cross Hospital, Nagaoka, Japan,

Hiroto TsuboiDepartment of Internal Medicine, University of Tsukuba, Tsukuba, Japan,

Shintaro HirataThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Fukuoka, Japan,

Yasumori IzumiDepartment of Rheumatology, NHO Nagasaki Medical Center, Nagasaki, Japan,

Taiichiro MiyashitaDepartment of Rheumatology, NHO Nagasaki Medical Center, Nagasaki, Japan, ;Miyashita Rheumatology Clinic, Nagasaki, Japan,

Keita FujikawaDepartment of Rheumatology, Japan Community Healthcare Organization (JCHO), Isahaya General Hospital, Nagasaki, Japan,

Hiroaki DobashiDivision of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Takamatsu, Japan,

Kentaro SusakiDivision of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Takamatsu, Japan,

Hisanori MorimotoDepartment of Internal Medicine, Mitoyo General Hospital, Kan'onji, Japan,

Kazutaka TakagiDivision of Hematology and Immunology, Maizuru-Kyousai Hospital, Kyoto, Japan,

Mitsuhiro KawanoDivision of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan,

Tomoki OriguchiLaboratory of Basic Physical Therapy Science, Nagasaki Graduate School of Health Sciences, Nagasaki, Japan,

Yoko WadaDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan,

Naoki TakahashiDivision of Nephrology, Department of General Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan,

Masanobu HorikoshiDepartment of Internal Medicine, University of Tsukuba, Tsukuba, Japan,

Hiroshi OgishimaDepartment of Internal Medicine, University of Tsukuba, Tsukuba, Japan,

Yasunori SuzukiDivision of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan,

Takafumi KawanamiDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan,

Haruka Kawanami IwaoDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan,

Tomoyuki SakaiDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan,

Yoshimasa FujitaDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan,

Toshihiro FukushimaDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan,

Masatoshi SaitoDivision of Respiratory Medicine, Kanazawa Medical University, Uchinada, Japan,

Ritsuro SuzukiDepartment of Oncology/Hematology, School of Medicine, Shimane University, Izumo, Japan,

Yuko MorikawaDepartment of Epidemiology and Public Health (School of Nursing), Kanazawa Medical University, Uchinada, Japan,

Tadashi YoshinoDepartment of Pathology, Okayama University Graduate School of Medicine, Okayama, Japan,

Shigeo NakamuraDepartment of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan,

Masaru KojimaDepartment of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine, Mibu, Japan, and

Nozomu KuroseDepartment of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada, Japan

Yasuharu SatoDepartment of Pathology, Okayama University Graduate School of Medicine, Okayama, Japan,

Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Fukuoka, Japan,

Susumu SugaiDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan,

Takayuki SumidaDepartment of Internal Medicine, University of Tsukuba, Tsukuba, Japan,

show all

A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease

Articles from other publishers (45)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease

Citations (50)

Read on this site (5)

Articles from other publishers (45)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date